Content about Mylan

December 22, 2010

Takeda and its subsidiary settled the patent suits it brought against generic drug makers that sought to develop their own versions of its diabetes treatment.

DEERFIELD, Ill., and OSAKA, Japan — Takeda and its subsidiary settled the patent suits it brought against generic drug makers that sought to develop their own versions of its diabetes treatment.

December 21, 2010

A judge recently blocked AstraZeneca from attempting to impede the development of generic versions of its popular cholesterol drug, according to published reports.

NEW YORK — A judge recently blocked AstraZeneca from attempting to impede the development of generic versions of its popular cholesterol drug, according to published reports.

December 21, 2010

A Mylan subsidiary has settled a lawsuit brought on by the Department of Justice four years ago.

BASKING RIDGE, N.J. — A Mylan subsidiary has settled a lawsuit brought on by the Department of Justice four years ago.

December 10, 2010

The Food and Drug Administration has approved a generic drug for hypertension made by Mylan.

PITTSBURGH — The Food and Drug Administration has approved a generic drug for hypertension made by Mylan.

Mylan announced Friday the approval of nifedipine extended-release tablets in the 30-mg, 60-mg and 90-mg strengths. The drug is a generic version of Bayer’s Adalat CC.

Nifedipine tablets had sales of around $82 million during the 12-month period ended in June, according to IMS Health.

December 7, 2010

The Food and Drug Administration has given tentative approval to a generic drug for HIV/AIDS made by Mylan subsidiary Matrix Labs for distribution in developing countries under the President’s Emergency Plan for AIDS Relief, Mylan said Tuesday.

PITTSBURGH — The Food and Drug Administration has given tentative approval to a generic drug for HIV/AIDS made by Mylan subsidiary Matrix Labs for distribution in developing countries under the President’s Emergency Plan for AIDS Relief, Mylan said Tuesday.

The tentative approval under PEPFAR covers Matrix’s abacavir sulfate tablets in the 60-mg strength. The drug is a generic version of ViiV Healthcare’s Ziagen, and is used to treat the disease in children.

November 18, 2010

Johnson & Johnson and the U.S. government are suing two generic drug makers to stop...

NEW YORK — Johnson & Johnson and the U.S. government are suing two generic drug makers to stop them from launching a generic drug for HIV, according to published reports.

 

Bloomberg reported Thursday that Tibotec, a subsidiary of J&J, and the government were separately suing Mylan and Lupin over a generic version of the drug Prezista (darunavir ethanolate), alleging patent infringement.

 

 

November 14, 2010

William Gibson, the science-fiction author who helped create the cyberpunk genre in the 1980s and...

WALTHAM, Mass. — William Gibson, the science-fiction author who helped create the cyberpunk genre in the 1980s and paved the way for “The Matrix” movie franchise, once said, “The future is already here—it’s just not evenly distributed.”

He was correct. Emerging technologies, ranging from computers to mobile phones, historically have migrated from the theoretical to the inaccessible to the aristocratic to the indispensable and finally to the mundane.

November 14, 2010

The world of generic drugs has a big year ahead of it. Actually, it has...

The world of generic drugs has a big year ahead of it. Actually, it has a few big years ahead of it. But 2011 in particular carries a certain symbolic value as the year in which Pfizer, the world’s biggest drug maker, loses control of its patent for the cholesterol-lowering drug Lipitor (atorvastatin calcium), the world’s top-selling drug.

November 14, 2010

K-V Pharmaceutical has created a new marketing subsidiary for generic drugs, the company said. K-V...

October 26, 2010

Sales and profits have increased at Mylan during the third quarter and over the year,...

PITTSBURGH Sales and profits have increased at Mylan during the third quarter and over the year, the generic drug maker said in an earnings report Tuesday.

Mylan said sales for the quarter ended Sept. 30 were $1.36 billion, with gross profits of $580.1 million. Sales and profits for the same period last year were $1.26 billion and $505 million, respectively. Sales and gross profit for the first nine months of the year were $4.02 billion and $1.64 billion, compared with $3.74 billion and $1.56 billion last year.

 

October 20, 2010

The Food and Drug Administration has approved a Mylan generic drug for Parkinson’s disease, Mylan...

PITTSBURGH The Food and Drug Administration has approved a Mylan generic drug for Parkinson’s disease, Mylan said Thursday.

 

The drug maker announced the approval of pramipexole dihydrochloride tablets in the 0.125-mg, 0.25-mg, 0.5-mg, 1-mg and 1.5-mg strengths. The drug is a generic version of Boehringer Ingelheim’s Mirapex.

 

 

October 18, 2010

A U.S. District Court denied a motion for a preliminary injunction filed by Mylan to...

PITTSBURGH A U.S. District Court denied a motion for a preliminary injunction filed by Mylan to prevent Canadian generic drug maker Apotex from making a generic version of an extended-release antidepressant drug, Mylan said Monday.

 

Mylan said the U.S. District Court for the District of New Jersey erred in its decision, and it intends to appeal.

 

 

October 14, 2010

The Food and Drug Administration has approved two generic drugs by Mylan for treating hypertension,...

PITTSBURGH The Food and Drug Administration has approved two generic drugs by Mylan for treating hypertension, Mylan said Friday.

 

The company announced the approval of losartan potassium and hydrochlorothiazide tablets in the 50/12.5-mg and 100/25-mg strengths, and losartan potassium tablets in the 25-mg, 50-mg and 100-mg strengths, generic versions of Merck’s Hyzaar and Cozaar, respectively. Mylan began marketing its version of Hyzaar in the 100/12.5-mg strength in April.

 

 

October 4, 2010

The Food and Drug Administration has approved a generic drug for HIV made by a...

PITTSBURGH The Food and Drug Administration has approved a generic drug for HIV made by a subsidiary of Mylan under a program that supplies drugs to people living with HIV in developing countries, Mylan said Tuesday.

 

October 3, 2010

The Food and Drug Administration has approved a generic chemotherapy drug made by Mylan....

PITTSBURGH The Food and Drug Administration has approved a generic chemotherapy drug made by Mylan.

 

The Pittsburgh-based drug maker said Monday that it had received approval for the injected drug fludarabine phosphate in the 25-mg-per-mL strength. The FDA determined the drug to be therapeutically equivalent to Teva Parenteral’s fludarabine phosphate.

 

 

September 30, 2010

Mylan has launched a generic version of a common antidepressant, the company said Friday....

PITTSBURGH Mylan has launched a generic version of a common antidepressant, the company said Friday.

 

Mylan announced the launch of bupropion hydrochloride extended-release tablets in the 150-mg and 300-mg strengths, a once-daily treatment for depression.

 

 

The drug is a generic version of GlaxoSmithKline’s Wellbutrin XL. Various versions of the drug had sales of around $752 million during the 12-month period ended in June, according to IMS Health.

 

September 26, 2010

Greenstone announced the launch of an authorized generic version of the Alzheimer’s disease drug Aricept...

September 21, 2010

Teva filed a complaint against a generic drug maker this week, asserting four patents for...

JERUSALEM Teva filed a complaint against a generic drug maker this week, asserting four patents for its multiple sclerosis drug are being infringed.

September 20, 2010

The Food and Drug Administration has approved a generic treatment for organ transplant patients....

PITTSBURGH The Food and Drug Administration has approved a generic treatment for organ transplant patients.

 

Mylan announced Tuesday the approval of tacrolimus capsules in the 0.5-mg, 1-mg and 5-mg strengths, and said it plans to launch the drug immediately. The drug is used to prevent rejection of transplanted organs.

 

 

September 6, 2010

Generic drug maker Mylan has managed to snag Bioniche Pharma Holdings sooner than expected, Mylan...

PITTSBURGH Generic drug maker Mylan has managed to snag Bioniche Pharma Holdings sooner than expected, Mylan said Tuesday. Mylan had announced its plans to buy Bioniche for $550 million in July.

 

July 22, 2010

Mylan has launched a generic treatment for acne, the company said Thursday....

PITTSBURGH Mylan has launched a generic treatment for acne, the company said Thursday.

Mylan announced the launch of minocycline hydrochloride extended-release tablets in the 45 mg, 90 mg and 135-mg strengths. The drug is a generic version of Solodyn ER, made by Medicis Pharmaceuticals Corp.

 

Minocycline ER had sales of around $496 million during the 12-month period ended in March, according to IMS Health.

 

July 14, 2010

Generic drug maker Mylan is hoping to gain entry into the injectable drug market with...

July 13, 2010

The Food and Drug Administration has approved a generic arthritis treatment made by Mylan, the...

PITTSBURGH The Food and Drug Administration has approved a generic arthritis treatment made by Mylan, the drug maker said Wednesday.

 

The FDA approved nabumetone tablets, a treatment for osteoarthritis and rheumatoid arthritis, in the 500 mg and 750-mg strengths.

 

 

June 17, 2010

The Food and Drug Administration has approved a generic cholesterol medication made by Mylan, the...

June 3, 2010

The Food and Drug Administration has approved Mylan’s version of a drug for complications related...